Clinical Trials Biz HVIVO To Quit Euronext, Focus On AIM
Vaccines testing firm hVIVO PLC said Monday it plans to cancel its listing on the Euronext Dublin bourse to consolidate trading its stock on London's junior alternative investment market AIM, a...To view the full article, register now.
Already a subscriber? Click here to view full article